[BDRX] YoY Quarter Result on 30-Sep-2020 [#Q3]

Stock
[BDRX] Biodexa Pharmaceuticals Plc
Announcement Date
29-Sep-2020
Financial Year
2020
Quarter
30-Sep-2020 [#Q3]
Profit Trend
QoQ- 72.62%
YoY-
Quarter Report
BDRX's Result
BDRX's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/09/22 30/09/21 30/09/20 30/09/17 30/09/16 30/09/15 CAGR
Revenue 42 116 89 88 258 1,986 526 -27.07%
PBT -1,815 -2,545 -1,358 -2,806 -3,145 -9,876 -2,991 -6.04%
Tax 59 248 205 421 311 3,898 389 -20.98%
NP -1,756 -2,298 -1,153 -2,385 -2,835 -5,979 -2,603 -4.79%
Tax Rate - - - - - - - -
Total Cost 1,797 2,413 1,242 2,472 3,093 7,965 3,128 -6.68%
Ratio Analysis
30/09/23 30/09/22 30/09/21 30/09/20 30/09/17 30/09/16 30/09/15 CAGR
NP Margin -4,230.12 -1,989.18 -1,302.82 -2,725.14 -1,098.64 -301.03 -495.24 30.72%
Per Share
30/09/23 30/09/22 30/09/21 30/09/20 30/09/17 30/09/16 30/09/15 CAGR
EPS -1.32 -185.31 -94.32 0.00 0.00 0.00 0.00 -
EPS Diluted -1.32 -185.31 -94.32 0.00 0.00 0.00 0.00 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.